Emerging molecular technologies for identifying the risk of second cancers.
Mayne
Susan T
ST
Yale School of Public Health, 60 College Street, P.O. Box 208034, New Haven, CT 06520-8034, USA. susan.mayne@yale.edu
Gruber
Stephen B
SB
D016588:Anticarcinogenic Agents / Q000494:pharmacology; D004272:DNA, Mitochondrial / Q000378:metabolism; D020022:Genetic Predisposition to Disease; D005821:Genetic Techniques; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D008495:Medical Oncology / Q000379:methods; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D012306:Risk; D018570:Risk Assessment
D016588:Anticarcinogenic Agents; D004272:DNA, Mitochondrial